One month version of Hikikomori Questionnaire-25 (HQ-25M): Development and initial validation.

Takahiro A. Kato; Yudai Suzuki; Kazumasa Horie; Alan R. Teo; Shinji Sakamoto

doi:10.1111/pcn.13499

One month version of Hikikomori Questionnaire-25 (HQ-25M): Development and initial validation.

Takahiro A. Kato, Yudai Suzuki, Kazumasa Horie, Alan R. Teo, Shinji Sakamoto

Psychiatry

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	188-189
Number of pages	2
Journal	Psychiatry and Clinical Neurosciences
Volume	77
Issue number	3
DOIs	https://doi.org/10.1111/pcn.13499
State	Published - Mar 2023

ASJC Scopus subject areas

General Neuroscience
Neurology
Clinical Neurology
Psychiatry and Mental health

Access to Document

10.1111/pcn.13499

Cite this

@article{e32ed5fbaa4545c29bca00c0444a4afd,

title = "One month version of Hikikomori Questionnaire-25 (HQ-25M): Development and initial validation.",

author = "Kato, {Takahiro A.} and Yudai Suzuki and Kazumasa Horie and Teo, {Alan R.} and Shinji Sakamoto",

note = "Funding Information: This study was approved by the Ethics Committees of Nihon University and Kyushu University. This online survey was administered by Cross Marketing, Inc., Tokyo. This study was supported in part by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS KAKENHI Grant Numbers: JP16H06403, JP18H04042, JP19K21591, JP20H01773 and JP22H00494), and the Japan Agency for Medical Research and Development (AMED: JP21wm0425010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This manuscript was edited by a native English speaker, Ms. Monica Natsumi Daudelin. Funding Information: This study was approved by the Ethics Committees of Nihon University and Kyushu University. This online survey was administered by Cross Marketing, Inc., Tokyo. This study was supported in part by Grants‐in‐Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS KAKENHI Grant Numbers: JP16H06403, JP18H04042, JP19K21591, JP20H01773 and JP22H00494), and the Japan Agency for Medical Research and Development (AMED: JP21wm0425010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This manuscript was edited by a native English speaker, Ms. Monica Natsumi Daudelin. ",

year = "2023",

month = mar,

doi = "10.1111/pcn.13499",

language = "English (US)",

volume = "77",

pages = "188--189",

journal = "Psychiatry and Clinical Neurosciences",

issn = "1323-1316",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - One month version of Hikikomori Questionnaire-25 (HQ-25M)

T2 - Development and initial validation.

AU - Kato, Takahiro A.

AU - Suzuki, Yudai

AU - Horie, Kazumasa

AU - Teo, Alan R.

AU - Sakamoto, Shinji

N1 - Funding Information: This study was approved by the Ethics Committees of Nihon University and Kyushu University. This online survey was administered by Cross Marketing, Inc., Tokyo. This study was supported in part by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS KAKENHI Grant Numbers: JP16H06403, JP18H04042, JP19K21591, JP20H01773 and JP22H00494), and the Japan Agency for Medical Research and Development (AMED: JP21wm0425010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This manuscript was edited by a native English speaker, Ms. Monica Natsumi Daudelin. Funding Information: This study was approved by the Ethics Committees of Nihon University and Kyushu University. This online survey was administered by Cross Marketing, Inc., Tokyo. This study was supported in part by Grants‐in‐Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS KAKENHI Grant Numbers: JP16H06403, JP18H04042, JP19K21591, JP20H01773 and JP22H00494), and the Japan Agency for Medical Research and Development (AMED: JP21wm0425010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This manuscript was edited by a native English speaker, Ms. Monica Natsumi Daudelin.

PY - 2023/3

Y1 - 2023/3

UR - http://www.scopus.com/inward/record.url?scp=85142903117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85142903117&partnerID=8YFLogxK

U2 - 10.1111/pcn.13499

DO - 10.1111/pcn.13499

M3 - Letter

C2 - 36305452

AN - SCOPUS:85142903117

SN - 1323-1316

VL - 77

SP - 188

EP - 189

JO - Psychiatry and Clinical Neurosciences

JF - Psychiatry and Clinical Neurosciences

IS - 3

ER -

One month version of Hikikomori Questionnaire-25 (HQ-25M): Development and initial validation.

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this